查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1912753

智慧气喘监测设备市场（按设备类型、监测技术、连接方式、性别、最终用户和分销管道划分）—2026-2032年全球预测

Intelligent Asthma Monitoring Devices Market by Device Type, Monitoring Technology, Connectivity, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年智慧气喘监测设备市值为5.7527亿美元，预计到2026年将成长至6.3735亿美元，到2032年将达到13.2027亿美元，复合年增长率为12.60%。

关键市场统计数据
基准年 2025 5.7527亿美元
预计年份：2026年 6.3735亿美元
预测年份 2032 1,320,270,000 美元
复合年增长率 (%) 12.60%

掌握智慧气喘监测的现代趋势，感测器融合、互联互通和临床需求正在重新定义病患管理和护理服务。

气喘治疗领域正经历着至关重要的技术变革，这场变革的驱动力来自微型感测器、无所不在的网路连接以及先进的数据分析技术的融合。从临床环境到家庭环境，智慧监测设备正从试验阶段走向诊疗路径的常规应用，实现持续的生理评估、药物依从性追踪以及环境风险检测。这项转变的驱动因素包括：临床医生对客观纵向数据的日益增长的需求、患者对减少气喘发作和提高自主性的渴望，以及支付方对基于绩效的报销模式的寻求。

明确推动智慧气喘护理设备设计、数据整合和推广应用路径的核心技术、临床和市场驱动因素。

目前智慧气喘监测的发展现况正受到多项变革性因素的影响，这些变革不仅加速了其普及应用，同时也提高了设备效能和实证依据的标准。首先，感测器技术日益成熟和多样化，使设备能够捕捉喘息的声学特征、透过生物感测器检测生化标誌物，并透过整合吸入感测器监测患者行为。这种技术上的广度使得监测系统能够应对各种应用场景，从即时检测病情加重到验证用药依从性，再到提供个人化的环境警报。

分析近期关税调整和贸易政策转变如何加剧智慧气喘设备生态系统的供应链复杂性、成本压力和策略采购选择。

2025年实施的关税和贸易政策调整对智慧气喘监测设备的产品开发、采购和定价策略带来了复杂的压力。由于许多核心零件，例如微机电系统（MEMS）、专用生物感测器元件、无线通讯模组和特定印刷基板组件等，都来自全球供应链，进口关税的增加推高了到岸成本，迫使製造商重新评估其筹资策略。因此，企业必须在自行承担额外成本、将其转嫁给买家或重组供应链以降低风险之间做出选择。

透过产品、技术、连接方式、最终用户和分销管道的细分，揭示智慧气喘解决方案的差异化设计重点和商业化路径。

细分市场分析揭示了不同设备类型、监测技术、连接方式、最终用户和通路所带来的独特需求驱动因素和设计要务。设备分类包括临床级和家用固定式监测器，每种监测器对精度、校准和资料安全的要求各不相同。行动应用程式支援患者参与和远端监测工作流程。智慧吸入器包括剂量计数器和吸入器技术感测器，剂量计数器又可进一步分为电子式和光学式，而吸入器技术感测器则采用基于流量或压力的方法。穿戴式追踪器种类繁多，从黏贴式贴片到腕带，其中黏贴式贴片本身就满足了不同的用户需求，因此需要同时关注黏合剂的化学性质和绑带的替代方案。这些设备差异将影响监管路径、临床检验方法和可用性设计重点。

评估医疗保健结构、管理体制和基础设施的区域差异如何影响智慧气喘监测的采用策略和商业化。

区域趋势将对智慧气喘监测的普及速度、监管预期和商业模式产生重大影响。在美洲地区，人们对能够展现明确临床疗效并可与现有电子健康记录 (EHR) 基础设施整合的设备表现出浓厚的兴趣。支付方的讨论主要集中在将设备使用与减少急诊就诊量挂钩的报销模式上，旨在促进设备製造商与医疗系统之间的合作。此外，美洲地区对可扩展的远距监测计画需求强劲，这些计画透过利用远端医疗的服务包来满足农村和医疗服务不足地区的需求。

呼吸监测领域设备製造商、软体创新者和医疗保健系统合作者的竞争定位、联盟趋势和能力集中度分析

智慧气喘监测领域的竞争格局错综复杂，既有成熟的医疗设备公司，也有新兴的数位医疗Start-Ups，以及来自其他产业的科技参与企业。领先的参与企业正致力于透过提升感测器精度、增强软体功能、产生临床证据以及与现有医疗流程无缝整合来实现差异化竞争。设备製造商与临床网路之间建立策略联盟十分普遍，这有助于加速检验和收集真实世界证据，从而为医保报销谈判提供支援。

为製造商、支付方和临床合作伙伴提供优化产品模组化、证据产生、互通性和供应链弹性的实用策略

产业领导者应采取多管齐下的方法，使产品开发与临床工作流程、支付方期望以及稳健的供应链策略保持一致。首先，他们投资于模组化平台，实现感测器互换和韧体升级，从而延长设备生命週期并降低长期总拥有成本。将模组化融入设计，使企业能够在保护产品投资的同时，快速回应技术进步和监管回馈。

概述一种严谨的混合方法研究方案，该方案结合了关键相关人员访谈、二手证据综合和专家检验，以获得可操作的市场洞察。

为确保研究结果的稳健性和相关性，本研究采用了多层次的调查方法。主要研究包括对临床医生、设备开发人员、采购专业人员和分销合作伙伴进行结构化访谈，以收集关于临床效用、采购障碍和最终用户体验的实际观点。次要研究则整合了监管文件、技术白皮书和同行评审文献，以阐明设备性能特征和监管趋势的背景。

总之，我们的综合分析表明，感测器、分析技术和营运策略的整合是推进所有医疗保健机构中智慧气喘护理的关键因素。

智慧气喘监测设备在临床需求、技术可能性以及不断变化的健康和经济奖励的交汇点上发挥关键作用。该市场的未来与其说取决于单一的技术创新，不如说取决于相关人员能否将可靠的传感器、强大的连接性和具有临床意义的分析功能整合到工作流程中，从而为患者和医疗服务提供者带来可衡量的价值。随着技术的成熟，我们预计，证据产生、互通性和使用者体验将成为推动产品普及的主要因素。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的智慧气喘监测设备市场

  • 固定显示器
  • 行动应用
  • 智慧吸入器
  • 穿戴式追踪器
    • 修补
      • 黏合剂类型
      • 带子
    • 腕带

9. 依监测技术分類的智慧气喘监测设备市场

  • 声波感测器
  • 生物感测器
    • 化学
    • 光学的
  • 数据分析
  • 环境感测器

第十章 智慧型气喘监测设备市场：连结性与性别

  • Bluetooth
    • BLE
    • 经典的
  • 细胞
  • Wi-Fi
    • Wi-Fi 5
    • Wi-Fi 6

第十一章 以最终用户分類的智慧气喘监测设备市场

  • 诊所
  • 居家照护
  • 医院
  • 研究所

第十二章 智慧气喘监测设备市场（依分销通路划分）

  • 直销
  • 批发商
  • 线上零售

第十三章 智慧气喘监测设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 智慧气喘监测设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国智慧气喘监测设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国智慧气喘监测设备市场

第十七章：中国智慧气喘监测设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Adherium Limited
  • AptarGroup, Inc.
  • GE HealthCare Technologies Inc.
  • Health Care Originals, Inc.
  • Koninklijke Philips NV
  • Microlife Corporation
  • NDD Medical Technologies, Inc.
  • Nihon Kohden Corporation
  • NuvoAir AB
  • Omron Healthcare Co., Ltd.
  • Phosphorus, Inc.
  • ResMed Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vitalograph Ltd.
Product Code: MRR-AE420CB13A77

The Intelligent Asthma Monitoring Devices Market was valued at USD 575.27 million in 2025 and is projected to grow to USD 637.35 million in 2026, with a CAGR of 12.60%, reaching USD 1,320.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 575.27 million
Estimated Year [2026] USD 637.35 million
Forecast Year [2032] USD 1,320.27 million
CAGR (%) 12.60%

Framing the contemporary dynamics of intelligent asthma monitoring where sensor convergence, connectivity, and clinical demand redefine patient management and care delivery

The landscape of asthma care is undergoing a decisive technological evolution driven by the convergence of miniaturized sensors, ubiquitous connectivity, and advanced data analytics. Across clinical settings and home environments, intelligent monitoring devices are transitioning from pilot deployments to integral elements of care pathways, enabling continuous physiological assessment, adherence tracking, and environmental risk detection. This transition is motivated by rising expectations from clinicians for objective longitudinal data, by patients seeking fewer exacerbations and greater autonomy, and by payers exploring outcomes-driven reimbursement models.

Emerging device classes-ranging from fixed clinical monitors to wearables and smart inhaler systems-are redefining how respiratory status is captured and acted upon. Alongside hardware improvements, software capabilities for signal processing, predictive algorithms, and user engagement are maturing, creating new opportunities for early intervention and personalized management. As a result, stakeholders across the value chain are recalibrating priorities: manufacturers must integrate multidisciplinary engineering, regulatory and clinical expertise; health systems must design workflows that translate device data into care decisions; and regulators are adapting frameworks to encompass connected diagnostics and therapeutic adjuncts.

Consequently, the introduction sets the stage for a pragmatic assessment of technological readiness, operational barriers, and the market behaviors that will determine which device profiles and business models achieve clinical traction. In the sections that follow, readers will find a synthesis of transformative shifts, trade-related pressures, segmentation intelligence, regional nuances, competitive dynamics, and concrete recommendations to inform strategic planning and investment decisions.

Identifying the pivotal technological, clinical, and market forces that are reshaping device design, data integration, and adoption pathways in intelligent asthma care

The intelligent asthma monitoring landscape is shaped by several transformative shifts that collectively accelerate adoption while raising the bar for device performance and evidence. First, sensor technology is becoming more robust and diversified, enabling devices to capture acoustic signatures of wheeze, biochemical markers via biosensors, and patient behaviour through integrated inhalation sensors. This technical breadth allows monitoring systems to address distinct clinical use cases, from real-time exacerbation detection to adherence verification and personalized environmental alerts.

Second, connectivity paradigms have matured beyond simple telemetry toward resilient, low-latency architectures that support edge processing, intermittent synchronization, and longitudinal data aggregation. This evolution reduces clinician burden by enabling concise, clinically relevant summaries rather than raw data streams. Third, software and analytics are driving value through predictive models and actionable insights that prioritize interventions with the greatest clinical impact. The integration of data from environmental sensors further enriches contextual understanding, linking triggers to physiological response and allowing for more precise patient counseling and targeted interventions.

Additionally, clinical acceptance is increasingly contingent on demonstrable outcomes and interoperability. Stakeholders now expect devices to produce validated endpoints that can be integrated into electronic health records and care pathways. Emerging reimbursement frameworks and value-based care initiatives emphasize measurable reductions in exacerbations and emergency utilization, thereby incentivizing devices that can generate reliable evidence. Finally, end-user experience-encompassing device ergonomics, ease of setup, and data privacy assurances-has become a decisive differentiator for broader market acceptance, especially in home care and consumer-facing segments.

Analyzing how recent tariff adjustments and trade-policy shifts have amplified supply chain complexity, cost pressures, and strategic sourcing choices across the intelligent asthma device ecosystem

The imposition of tariffs and trade-policy adjustments in 2025 has introduced a complex set of pressures that reverberate across product development, procurement, and pricing strategies for intelligent asthma monitoring devices. Because many core components-such as microelectromechanical systems, specialized biosensor elements, wireless communication modules, and certain printed circuit assemblies-are manufactured in global supply hubs, escalated import duties increase landed costs and compel manufacturers to reassess sourcing strategies. Consequently, firms face a choice between absorbing incremental costs, passing them through to buyers, or restructuring supply chains to mitigate exposure.

In practice, some manufacturers have responded by accelerating supplier diversification and qualifying alternate vendors in tariff-exempt jurisdictions. Concurrently, others have shifted investment toward regional manufacturing or assembly capacity to reduce cross-border dependencies and improve control over quality and lead times. These adjustments often require capital expenditure and lead-time investment, but they can enhance resilience and provide strategic flexibility in the medium term. Meanwhile, distributors and channel partners report tighter margin pressure, which affects promotional activities and the economics of bundled offerings that combine hardware, software subscriptions, and services.

Regulatory compliance and documentation requirements have also become more scrutinized at customs checkpoints, increasing administrative overhead for companies that rely on cross-border shipments of prototype and pre-production units for clinical trials. For early-stage innovators, these additional frictions can slow clinical validation timelines and create funding runway challenges. On the demand side, health systems and payers are increasingly sensitive to total cost of ownership, prompting procurement teams to seek devices with longer lifecycle support, modular upgrade paths, and clear evidence of reduced downstream costs. Therefore, the cumulative impact of tariff dynamics is a heightened emphasis on operational agility, localization where feasible, and contractual structures that balance risk across supply chain partners.

Deconstructing product, technology, connectivity, end-user, and distribution segments to reveal differentiated design priorities and commercialization pathways for intelligent asthma solutions

Segment-level analysis reveals distinct demand drivers and design imperatives across device types, monitoring technologies, connectivity modalities, end users, and distribution routes. Within device typologies, fixed monitors occupy both clinical grade installations and home-based deployments, each with divergent requirements for accuracy, calibration, and data security; mobile applications support patient engagement and remote monitoring workflows; smart inhalers include dose counters and inhalation technique sensors, with dose counters further differentiated into electronic and optical counters while inhalation technique sensors utilize flow or pressure-based modalities; wearable trackers range from adhesive patches to wristbands, and adhesive patches themselves demand attention to both adhesive chemistry and strap alternatives to accommodate diverse user needs. These device variations dictate regulatory trajectories, clinical validation approaches, and usability design priorities.

From a technology standpoint, acoustic sensors, biosensors, data analytics, and environmental sensors contribute complementary insights. Biosensors bifurcate into chemical and optical implementations, each with trade-offs in specificity, calibration needs, and integration complexity. Connectivity choices-including Bluetooth with BLE and Classic variants, cellular solutions, and Wi-Fi with Wi-Fi 5 and Wi-Fi 6 profiles-shape device power budgets, data throughput, and deployment scenarios, particularly where continuous monitoring or high-fidelity signal capture is required.

End-user segmentation-spanning clinics, home care settings, hospitals, and research laboratories-introduces distinct expectations for integration, service-level agreements, and clinical workflows. Distribution channels such as direct sales, distributor networks, online retail platforms, and pharmacies influence pricing transparency, after-sales support models, and the feasibility of bundled service offerings. Taken together, this segmentation mosaic underscores that a one-size-fits-all product strategy is unlikely to succeed; rather, winning propositions will tailor sensor selection, connectivity stacks, and user experiences to defined clinical and commercial segments while ensuring modularity to adapt to evolving requirements.

Evaluating how regional healthcare structures, regulatory regimes, and infrastructure variances shape adoption strategies and commercialization for intelligent asthma monitoring

Regional dynamics materially influence adoption rhythms, regulatory expectations, and commercial models for intelligent asthma monitoring. In the Americas, there is pronounced interest in devices that demonstrate clear clinical outcomes and integrate with existing electronic health record infrastructure. Payer conversations increasingly center on reimbursement models that align device usage with reduced acute care utilization, motivating collaborations between device makers and health systems. Moreover, the Americas exhibit a strong appetite for scalable remote monitoring programs that address rural and underserved populations through telehealth-enabled service bundles.

In Europe, the Middle East and Africa, regulatory harmonization and nuanced national reimbursement frameworks require tailored market entry strategies. Health technology assessment processes and data protection regulations prompt device developers to prioritize clinical evidence and robust privacy controls. Meanwhile, demand in certain MEA markets is shaped by infrastructure constraints and the need for solutions that operate reliably in variable connectivity environments, favoring devices with flexible synchronization and offline data capture capabilities.

Asia-Pacific presents a heterogeneous landscape characterized by rapid technology adoption in urban centers, a growing middle class seeking digital health services, and robust manufacturing ecosystems. This region often acts as both a market and a supply base, offering competitive component sourcing but also exposing companies to trade-policy volatility. Across all regions, successful strategies balance local clinical validation, partnership with established care providers, and adaptive distribution models that reflect payer mix and procurement practices.

Mapping competitive positioning, partnership trends, and capability concentration among device makers, software innovators, and health system collaborators in respiratory monitoring

Competitive dynamics in the intelligent asthma monitoring space are shaped by a mix of established medical device firms, emergent digital health startups, and cross-sector technology entrants. Leading entrants focus on differentiating through sensor accuracy, software sophistication, clinical evidence generation, and seamless integration with care workflows. Strategic partnerships between device manufacturers and clinical networks are common, enabling accelerated validation and real-world evidence collection that supports reimbursement discussions.

Mergers and collaborations have concentrated capabilities in areas such as advanced signal processing, cloud-based analytics, and secure interoperability frameworks. Startups often compete on agility and user-centric design, while incumbents leverage regulatory experience and scale to support large institutional deployments. Investors and corporate development teams are watching for platforms that reduce friction for clinicians-those that translate continuous device signals into actionable clinical alerts and integrate with care pathways without increasing workload.

Intellectual property around sensor modalities, algorithmic approaches to exacerbation prediction, and methods for ensuring data integrity is a distinguishing factor. In parallel, data privacy, cybersecurity posture, and compliance with health-data regulations remain core requirements that influence partnership selection and procurement. Ultimately, companies that combine robust clinical validation, scalable software platforms, and clear value propositions for payers and providers will gain preferential access to institution-level contracts and long-term reimbursement arrangements.

Actionable strategies for manufacturers, payers, and clinical partners to optimize product modularity, evidence generation, interoperability, and supply chain resilience

Industry leaders should pursue a multifaceted approach that aligns product development with clinical workflows, payer expectations, and resilient supply-chain strategies. First, invest in modular platforms that allow for sensor interchangeability and firmware upgrades to extend device lifecycles and reduce long-term total cost of ownership. By designing for modularity, companies can adapt rapidly to technology advances and regulatory feedback while protecting product investments.

Second, prioritize clinical validation pathways that generate actionable, peer-reviewed evidence demonstrating reductions in exacerbations, emergency visits, or medication overuse. Close collaboration with health systems for pragmatic trials and real-world evidence studies will accelerate reimbursement dialogues and broaden clinical adoption. Third, strengthen data interoperability by implementing standards-based APIs and working toward seamless integration with electronic health records and remote patient monitoring portals to reduce friction for clinicians.

Fourth, address supply-chain risk by qualifying multiple suppliers, exploring regional assembly options, and embedding tariff sensitivity into sourcing decisions to maintain price competitiveness. Fifth, focus on the end-user experience through human-centered design to improve adherence and minimize device abandonment; simple onboarding, clear feedback loops, and trustworthy privacy communications are essential. Finally, cultivate strategic partnerships with distribution channels that align incentives, whether through direct sales for institutional contracts or omnichannel approaches that combine online retail and pharmacy collaborations for consumer-facing deployments.

Outlining a rigorous mixed-method research approach that integrates primary stakeholder interviews, secondary evidence synthesis, and expert validation for actionable market intelligence

The research underpinning these insights combined a layered methodology to ensure robustness and relevance. Primary research involved structured interviews with clinicians, device developers, procurement specialists, and distribution partners to capture frontline perspectives on clinical utility, procurement barriers, and end-user experience. Secondary research synthesized regulatory documents, technology white papers, and peer-reviewed literature to contextualize device performance characteristics and regulatory trends.

Data triangulation was applied to reconcile divergent stakeholder views and validate thematic findings through cross-referencing of interview insights with secondary evidence. Expert panel reviews provided iterative feedback on analytic assumptions, ensuring that interpretations of technology readiness, clinical adoption barriers, and regional nuances were grounded in practitioner realities. Quality control measures included methodological transparency, documentation of interview instruments, and systematic coding of qualitative data to surface recurring patterns.

Finally, segmentation mapping linked product attributes, technology choices, and connectivity profiles to end-user needs and distribution models, enabling practical recommendations. The research avoided reliance on single-source proprietary estimates and emphasized evidence-based, reproducible analysis to support strategic decision-making.

Concluding synthesis highlighting the integration of sensors, analytics, and operational strategies as the decisive factors in advancing intelligent asthma care across care settings

Intelligent asthma monitoring devices occupy a pivotal role at the intersection of clinical need, technological capability, and evolving health-economic incentives. The trajectory of this market will be determined less by single innovations and more by the ability of stakeholders to integrate reliable sensors, resilient connectivity, and clinically meaningful analytics into workflows that deliver measurable value to patients and providers. As technology matures, emphasis will shift to evidence generation, interoperability, and user experience as primary determinants of adoption.

Organizations that proactively manage supply-chain exposures, design for modularity, and prioritize collaborative clinical validation will be best positioned to capture durable opportunities. Meanwhile, regional nuances in regulation, reimbursement, and infrastructure demand adaptive commercial strategies. By focusing on these strategic imperatives, manufacturers, payers, and clinical leaders can convert technological potential into practical improvements in care delivery and patient outcomes. The synthesized insights in this executive summary provide a foundation for more detailed exploration and targeted action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intelligent Asthma Monitoring Devices Market, by Device Type

  • 8.1. Fixed Monitors
  • 8.2. Mobile Apps
  • 8.3. Smart Inhalers
  • 8.4. Wearable Trackers
    • 8.4.1. Patches
      • 8.4.1.1. Adhesive
      • 8.4.1.2. Strap
    • 8.4.2. Wristbands

9. Intelligent Asthma Monitoring Devices Market, by Monitoring Technology

  • 9.1. Acoustic Sensors
  • 9.2. Biosensors
    • 9.2.1. Chemical
    • 9.2.2. Optical
  • 9.3. Data Analytics
  • 9.4. Environmental Sensors

10. Intelligent Asthma Monitoring Devices Market, by Connectivity

  • 10.1. Bluetooth
    • 10.1.1. Ble
    • 10.1.2. Classic
  • 10.2. Cellular
  • 10.3. Wi-Fi
    • 10.3.1. Wi-Fi 5
    • 10.3.2. Wi-Fi 6

11. Intelligent Asthma Monitoring Devices Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals
  • 11.4. Research Laboratories

12. Intelligent Asthma Monitoring Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail

13. Intelligent Asthma Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intelligent Asthma Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intelligent Asthma Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intelligent Asthma Monitoring Devices Market

17. China Intelligent Asthma Monitoring Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adherium Limited
  • 18.6. AptarGroup, Inc.
  • 18.7. GE HealthCare Technologies Inc.
  • 18.8. Health Care Originals, Inc.
  • 18.9. Koninklijke Philips N.V.
  • 18.10. Microlife Corporation
  • 18.11. NDD Medical Technologies, Inc.
  • 18.12. Nihon Kohden Corporation
  • 18.13. NuvoAir AB
  • 18.14. Omron Healthcare Co., Ltd.
  • 18.15. Phosphorus, Inc.
  • 18.16. ResMed Inc.
  • 18.17. Teva Pharmaceutical Industries Ltd.
  • 18.18. Vitalograph Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 203. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 205. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 206. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 236. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 238. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 239. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 247. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 249. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 250. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)